NOVODX Corporation

NOVODX Corporation develops handheld at-home diagnostic screening infrastructure and consumer health platforms. The company's primary product, GoldN Companion, is a portable, smartphone-connected device designed to perform biomarker-based health screenings in 15 minutes or less. The platform supports multiple indications and features an AI assistant that guides users through screening procedures, contextualizes results, and maintains longitudinal health records. The device operates without internet connectivity for testing but requires Bluetooth and mobile app connectivity for data syncing and AI-powered insights. Test cassettes are single-use; the reusable handheld platform supports multiple biomarker analyses. NOVODX emphasizes practical, accessible design suitable for home use, field programs, and resource-limited settings. The company maintains HIPAA-compliant cloud infrastructure for data storage and user management. GoldN Companion is currently under development and not FDA-cleared or available for commercial sale in the US or internationally as of the site's last update. The platform is designed for consumer and professional deployment, with a stated mission to make health screenings simple, accessible, and trustworthy. Founded by CEO Nancy Torres, NOVODX positions itself at the intersection of consumer health technology and point-of-care diagnostics, targeting households and healthcare professionals.